CULLIA, GREGORIO
CULLIA, GREGORIO
Dipartimento di Scienze Farmaceutiche
3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death
2022 R. Pacchiana, N. Mullappilly, A. Pinto, S. Bova, S. Forciniti, G. Cullia, E. Dalla Pozza, E. Bottani, I. Decimo, I. Dando, S. Bruno, P. Conti, M. Donadelli
Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign
2020 P. Linciano, G. Cullia, C. Borsari, M. Santucci, S. Ferrari, G. Witt, S. Gul, M. Kuzikov, B. Ellinger, N. Santarem, A. Cordeiro da Silva, P. Conti, M.L. Bolognesi, M. Roberti, F. Prati, F. Bartoccini, M. Retini, G. Piersanti, A. Cavalli, L. Goldoni, S.M. Bertozzi, F. Bertozzi, E. Brambilla, V. Rizzo, D. Piomelli, A. Pinto, T. Bandiera, M.P. Costi
Covalent Inhibitors of Plasmodium falciparum Glyceraldehyde 3-Phosphate Dehydrogenase with Antimalarial Activity in Vitro
2019 G. Cullia, S. Bruno, S. Parapini, M. Margiotta, L. Tamborini, A. Pinto, A. Galbiati, A. Mozzarelli, M. Persico, A. Paladino, C. Fattorusso, D. Taramelli, P. Conti
Folates in Trypanosoma brucei: achievements and opportunities
2018 G. Cullia, L. Tamborini, P. Conti, C. De Micheli, A. Pinto
ENZYME INHIBITORS AS POTENTIAL ANTIPARASITIC AGENTS
2017 G. Cullia
Design and synthesis of novel enzyme inhibitors as potential antiparasitic agents
2016 G. Cullia
Design, synthesis and biological characterization of PfGAPDH inhibitors
2016 G. Cullia, A. Pinto, S. Bruno, S. Parapini, L. Tamborini, A. Mozzarelli, D. Taramelli, C. De Micheli, P. Conti
Synthesis and pharmacological evaluation of conformationally constrained glutamic acid higher homologues
2016 L. Tamborini, G. Cullia, B. Nielsen, C. De Micheli, P. Conti, A. Pinto
Synthesis and biological evaluation of new ligands designed to selectively interact with kainate receptors
2016 G. Cullia, F. Mastronardi, A. Pinto, L. Tamborini, L. Marconi, C. De Micheli, P. Conti
Selectivity of 3-bromo-isoxazoline inhibitors between human and Plasmodium falciparum glyceraldehyde-3-phosphate dehydrogenases
2016 S. Bruno, M. Margiotta, A. Pinto, G. Cullia, P. Conti, C. De Micheli, A. Mozzarelli
The inhibition of cysteine proteases rhodesain and TbCatB : A valuable approach to treat human african trypanosomiasis
2016 R. Ettari, S. Previti, L. Tamborini, G. Cullia, S. Grasso, M. Zappalà
Inspired by Nature : The 3-Halo-4,5-dihydroisoxazole Moiety as a Novel Molecular Warhead for the Design of Covalent Inhibitors
2016 A. Pinto, L. Tamborini, G. Cullia, P. Conti, C. De Micheli
Bicyclic γ-amino acids as inhibitors of γ-aminobutyrate aminotransferase
2016 A. Pinto, L. Tamborini, E. Pennacchietti, A. Coluccia, R. Silvestri, G. Cullia, C. De Micheli, P. Conti, D. De Biase
Characterization of 2,4-Diamino-6-oxo-1,6-dihydropyrimidin-5-yl Ureido Based Inhibitors of Trypanosoma brucei FolD and Testing for Antiparasitic Activity
2015 T.C. Eadsforth, A. Pinto, R. Luciani, L. Tamborini, G. Cullia, C. De Micheli, L. Marinelli, S. Cosconati, E. Novellino, L. Lo Presti, A. Cordeiro da Silva, P. Conti, W.N. Hunter, M.P. Costi
Efficient synthesis of kainic acid analogues
2013 L. Tamborini, F. Mastronardi, G. Cullia, R. Ettari, C. De Micheli
3-Carboxy-pyrazolinalanine as a new scaffold for developing potent and selective NMDA receptor antagonists
2013 L. Tamborini, A. Pinto, F. Mastronardi, M.C. Iannuzzi, G. Cullia, B. Nielsen, C. De Micheli, P. Conti